---
document_datetime: 2024-11-06 15:48:36
document_pages: 7
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/xerava-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: xerava-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 4.7642027
conversion_datetime: 2026-02-09 22:06:37.589252
docling_version:
  docling-serve: 1.12.0
  docling-jobkit: 1.10.1
  docling: 2.72.0
  docling-core: 2.63.0
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Xerava

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                           | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| T/0028               | Transfer of Marketing Authorisation                                                                                                             | 26/09/2024                          | 24/10/2024                                  | SmPC, Labelling and PL           |           |
| IAIN/0027            | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer | 20/08/2024                          | 24/10/2024                                  | Annex II and PL                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |            |            |                 |                                                                                                                                            |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10718 /202308 | Periodic Safety Update EU Single assessment - eravacycline                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 25/04/2024 | 20/06/2024 | PL              | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10718/202308. |
| IB/0026/G           | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 03/06/2024 | n/a        |                 |                                                                                                                                            |
| IAIN/0024           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release -                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 11/05/2023 | 29/04/2024 | Annex II and PL |                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|                     | Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                              |            |            |                                  |                                                                                                                                                                                                                                                                      |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0023              | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                          | 23/02/2023 | 12/04/2023 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Xerava in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| PSUSA/10718 /202208 | Periodic Safety Update EU Single assessment - eravacycline                                                                                                                                                                                                                                                                                                                                       | 16/03/2023 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                    |
| PSUSA/10718 /202202 | Periodic Safety Update EU Single assessment - eravacycline                                                                                                                                                                                                                                                                                                                                       | 29/09/2022 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                    |
| IB/0021/G           | This was an application for a group of variations. B.II.b.z - Change in manufacture of the Finished Product - Other variation B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                               | 21/07/2022 | n/a        |                                  |                                                                                                                                                                                                                                                                      |
| IA/0020/G           | This was an application for a group of variations. B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor | 30/05/2022 | n/a        |                                  |                                                                                                                                                                                                                                                                      |

<div style=\"page-break-after: always\"></div>

|                     | changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor   |            |     |                                   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10718 /202108 | Periodic Safety Update EU Single assessment - eravacycline                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 10/03/2022 | n/a | PRAC Recommendation - maintenance |
| IB/0017/G           | This was an application for a group of variations. B.I.d.1.z - Stability of AS - Change in the re-test                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 26/10/2021 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|                     | period/storage period or storage conditions - Other variation B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                                                                         |            |            |                                  |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| PSUSA/10718 /202102 | Periodic Safety Update EU Single assessment - eravacycline                                                                                                                                                                                                                                                                                                                                                                                                                                   | 30/09/2021 | n/a        |                                  | PRAC Recommendation - maintenance |
| II/0012             | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                            | 08/07/2021 | 29/06/2022 | SmPC                             |                                   |
| IAIN/0016/G         | This was an application for a group of variations. B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 09/06/2021 | 29/06/2022 | SmPC, Annex II, Labelling and PL |                                   |
| IAIN/0015           | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                           | 10/05/2021 | n/a        |                                  |                                   |
| T/0013              | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 08/04/2021 | 16/04/2021 | SmPC, Labelling and              |                                   |

<div style=\"page-break-after: always\"></div>

|                     |                                                                                                                                                                        |            |            | PL                               |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| PSUSA/10718 /202008 | Periodic Safety Update EU Single assessment - eravacycline                                                                                                             | 11/03/2021 | n/a        |                                  | PRAC Recommendation - maintenance |
| X/0009              | Annex I_2.(c) Change or addition of a new strength/potency                                                                                                             | 10/12/2020 | 11/02/2021 | SmPC, Annex II, Labelling and PL |                                   |
| PSUSA/10718 /202002 | Periodic Safety Update EU Single assessment - eravacycline                                                                                                             | 01/10/2020 | n/a        |                                  | PRAC Recommendation - maintenance |
| IB/0008             | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data | 27/03/2020 | n/a        |                                  |                                   |
| PSUSA/10718 /201908 | Periodic Safety Update EU Single assessment - eravacycline                                                                                                             | 12/03/2020 | n/a        |                                  | PRAC Recommendation - maintenance |
| PSUSA/10718 /201902 | Periodic Safety Update EU Single assessment - eravacycline                                                                                                             | 05/09/2019 | n/a        |                                  | PRAC Recommendation - maintenance |
| IB/0006             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                          | 06/06/2019 | n/a        |                                  |                                   |
| IB/0004             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                              | 25/04/2019 | 28/02/2020 | SmPC                             |                                   |
| IB/0003             | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a                                                           | 15/04/2019 | n/a        |                                  |                                   |

<div style=\"page-break-after: always\"></div>

|         | period/storage period supported by real time                                                                                                                                                                                            |            |            |                        | re-test data   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------|
| IB/0002 | B.I.b.1.h - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition or replacement (excl. Biol. or immunol. substance) of a specification parameter as a result of a safety or | 28/03/2019 | n/a        |                        | quality issue  |
| IB/0001 | B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the currently approved pack sizes                                                  | 04/03/2019 | 28/02/2020 | SmPC, Labelling and PL | the range of   |